Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.
2.

The COMmon control of hypErtenSion and Therapeutic Attitudes in Belgium and Luxemburg study (COME STAI).

van de Borne P, Missault L, Persu A, Van Mieghem W.

Acta Cardiol. 2016 Feb;71(1):35-40. doi: 10.2143/AC.71.1.3132095.

PMID:
26853251
3.

Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET).

Mancia G, Parati G, Bilo G, Gao P, Fagard R, Redon J, Czuriga I, Polák M, Ribeiro JM, Sanchez R, Trimarco B, Verdecchia P, van Mieghem W, Teo K, Sleight P, Yusuf S.

Hypertension. 2012 Dec;60(6):1400-6. doi: 10.1161/HYPERTENSIONAHA.112.199562. Epub 2012 Oct 15.

PMID:
23071122
4.

A critical review on telemonitoring in heart failure.

Gurné O, Conraads V, Missault L, Mullens W, Vachierys JL, Van Mieghem W, Droogne W, Pouleur AC, Troisfontaine P, Huez S, Nellessens E, Peperstraete B, Blouardo P, Vanhaecke J, Raes D; Belgian Working Group on Heart Failure.

Acta Cardiol. 2012 Aug;67(4):439-44. Review.

PMID:
22997998
5.

Stroke prevention in atrial fibrillation: current status and emerging therapies.

Van Mieghem W, Mairesse G, Missault L, Vanhooren G, Verhamme P, Dupont A.

Acta Cardiol. 2012 Apr;67(2):161-7. Review.

PMID:
22641973
6.

Apixaban in patients with atrial fibrillation.

Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, Flaker G, Avezum A, Hohnloser SH, Diaz R, Talajic M, Zhu J, Pais P, Budaj A, Parkhomenko A, Jansky P, Commerford P, Tan RS, Sim KH, Lewis BS, Van Mieghem W, Lip GY, Kim JH, Lanas-Zanetti F, Gonzalez-Hermosillo A, Dans AL, Munawar M, O'Donnell M, Lawrence J, Lewis G, Afzal R, Yusuf S; AVERROES Steering Committee and Investigators.

N Engl J Med. 2011 Mar 3;364(9):806-17. doi: 10.1056/NEJMoa1007432. Epub 2011 Feb 10.

7.

Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial.

Duckers HJ, Houtgraaf J, Hehrlein C, Schofer J, Waltenberger J, Gershlick A, Bartunek J, Nienaber C, Macaya C, Peters N, Smits P, Siminiak T, van Mieghem W, Legrand V, Serruys PW.

EuroIntervention. 2011 Feb;6(7):805-12. doi: 10.4244/EIJV6I7A139.

8.

Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.

Mallion JM, Omboni S, Barton J, Van Mieghem W, Narkiewicz K, Panzer PK, Puig JG, Stefanadis C, Zweiker R; Study Group.

Blood Press Suppl. 2011 Apr;1:3-11. doi: 10.3109/08037051.2010.532332. Epub 2010 Nov 23.

PMID:
21091270
9.

Are ACE-inhibitors or ARB's still needed for cardiovascular prevention in high risk patients? Insights from profess and transcend.

Van Mieghem W, Billiouw JM, Brohet C, Dupont AG, Gazagnes MD, Heller F, Krzesinski JM, Missault L, Persu A, Piérard L, Rottiers R, Vanhooren G, Vervaet P, Herman AG.

Acta Clin Belg. 2010 Mar-Apr;65(2):107-14.

10.

Prevention of major cardiovascular events with an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker early or late after stroke.

Van Mieghem W.

J Hypertens Suppl. 2009 Jun;27(2):S26-31. doi: 10.1097/01.hjh.0000354517.82698.51.

PMID:
19491619
11.

Centralized Pan-European survey on the undertreatment of hypercholesterolaemia (CEPHEUS).

Hermans MP, Van Mieghem W, Vandenhoven G, Vissers E.

Acta Cardiol. 2009 Apr;64(2):177-85.

PMID:
19476109
12.

Doppler measurement of renal interlobar vein impedance index in uncomplicated and preeclamptic pregnancies.

Gyselaers W, Molenberghs G, Van Mieghem W, Ombelet W.

Hypertens Pregnancy. 2009 Feb;28(1):23-33. doi: 10.1080/10641950802233056.

PMID:
19165667
13.

Lessons from ONTARGET.

Berlaimont V, Billiouw JM, Brohet C, Dupont AG, Gazagnes MD, Heller F, Krzesinski JM, Missault L, Persu A, Piérard L, Rottiers R, Vanhooren G, Van Mieghem W, Vervaet P, Herman AG.

Acta Clin Belg. 2008 May-Jun;63(3):142-51. Review.

14.

Efficacy of atorvastatin after LDL-cholesterol-based dose selection in high risk dyslipidaemic patients: results of the target dose study.

Ducobu J, Claeys M, Commers K, Van Mieghem W, Nachtergaele H, Vandenbroucke M, Deforce J.

Curr Med Res Opin. 2007 Aug;23(8):1821-7.

PMID:
17609019
15.

Hydrochlorothiazide-associated noncardiogenic pulmonary oedema and shock: a case report and review of the literature.

Goetschalckx K, Ceuppens J, Van Mieghem W.

Acta Cardiol. 2007 Apr;62(2):215-20. Review.

PMID:
17536614
16.

Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events.

Active Steering Committee; ACTIVE Investigators, Connolly S, Yusuf S, Budaj A, Camm J, Chrolavicius S, Commerford PJ, Flather M, Fox KA, Hart R, Hohnloser S, Joyner C, Pfeffer M, Anand I, Arthur H, Avezum A, Bethala-Sithya M, Blumenthal M, Ceremuzynski L, De Caterina R, Diaz R, Flaker G, Frangin G, Franzosi MG, Gaudin C, Golitsyn S, Goldhaber S, Granger C, Halon D, Hermosillo A, Hunt D, Jansky P, Karatzas N, Keltai M, Lanas F, Lau CP, Le Heuzey JY, Lewis BS, Morais J, Morillo C, Oto A, Paolasso E, Peters RJ, Pfisterer M, Piegas L, Pipillis T, Proste C, Sitkei E, Swedberg K, Synhorst D, Talajic M, Trégou V, Valentin V, van Mieghem W, Weintraub W, Varigos J.

Am Heart J. 2006 Jun;151(6):1187-93.

PMID:
16781218
17.

Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy.

Rousseau MF, Gurné O, Duprez D, Van Mieghem W, Robert A, Ahn S, Galanti L, Ketelslegers JM; Belgian RALES Investigators.

J Am Coll Cardiol. 2002 Nov 6;40(9):1596-601. Erratum in: J Am Coll Cardiol. 2003 Nov 19;42(10):1865.

18.

Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin.

Cohen M, Théroux P, Borzak S, Frey MJ, White HD, Van Mieghem W, Senatore F, Lis J, Mukherjee R, Harris K, Bigonzi F; ACUTE II Investigators.

Am Heart J. 2002 Sep;144(3):470-7.

PMID:
12228784
20.

Verapamil as prophylactic treatment for atrial fibrillation after lung operations.

Van Mieghem W, Tits G, Demuynck K, Lacquet L, Deneffe G, Tjandra-Maga T, Demedts M.

Ann Thorac Surg. 1996 Apr;61(4):1083-5; discussion 1086.

PMID:
8607661

Supplemental Content

Loading ...
Support Center